1974
DOI: 10.1111/j.1744-313x.1974.tb00321.x
|View full text |Cite
|
Sign up to set email alerts
|

A Skin‐graft Enhancing Antiserum Which Recognizes Two New B‐cell Alloantigens Determined by the Major Histo‐compatibility Locus of the Mouse

Abstract: SUMMARY A mouse alloantiserum, raised by immunizing B10.D2/n mice with B10.M spleen, has been found to retain cytotoxic activity against a proportion of lymph node cells even after exhaustive absorption with B10.M red blood cells. Titration and absorption with a number of strains showed that the absorbed serum retained antibodies against two new specificities. The absorbed serum gave significant enhancement of B10.M skin grafts on B10.D2 and reacted mainly with B cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
16
0

Year Published

1975
1975
1991
1991

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 22 publications
(19 citation statements)
references
References 9 publications
3
16
0
Order By: Relevance
“…Titration against B10.D2 lymph node cells of BIO.A anti-B10.D2 antisera (S117) raised against different cell types. Individual curves represent the activity of serum pools from groups of mice that all received two sequential skin grafts followed by one of the following: spleen cells ( 0 ) ; thymus cells (=); whole blood (v); blood leukocytes (0); purified RBC (12); purified blood platelets ( X I ) . a) Antisera (S117), illustrated also in Fig.…”
Section: T H E Influence Of Non-mhc Incompatibilitiesmentioning
confidence: 99%
“…Titration against B10.D2 lymph node cells of BIO.A anti-B10.D2 antisera (S117) raised against different cell types. Individual curves represent the activity of serum pools from groups of mice that all received two sequential skin grafts followed by one of the following: spleen cells ( 0 ) ; thymus cells (=); whole blood (v); blood leukocytes (0); purified RBC (12); purified blood platelets ( X I ) . a) Antisera (S117), illustrated also in Fig.…”
Section: T H E Influence Of Non-mhc Incompatibilitiesmentioning
confidence: 99%
“…H-2. 58, 59 have Ia like properties and are not expressed on RBC (Archer et al 1974), but 59 and Ia.3 are probably absent because of no reaction against the same H-2b and H-2' 4 cells. The serum thus We have noted that H-2' -+ H-2d sera frequently react with H-2' lymphocytes with a characteristically low release or biphasic cytotoxicity profile.…”
Section: Serum B1oa 3 B10d2mentioning
confidence: 99%
“…The serum thus We have noted that H-2' -+ H-2d sera frequently react with H-2' lymphocytes with a characteristically low release or biphasic cytotoxicity profile. This reaction was assumed to be due to H-2.45 and, of course, may now involve the Ia-like specificities 58 and 59 (Archer et al 1974). An anti-H-2' serum (S69) was absorbed with I/St RBC.…”
Section: Serum B1oa 3 B10d2mentioning
confidence: 99%
See 1 more Smart Citation
“…The presence of H-2" was sought using serum A175 (A.SW anti-B10.BR spleen-enlarging lymphoma; H-2' anti-H-2 k ) by a standard complement-mediated 51 Cr-release cytotoxicity test (Archer et al 1974). This combination assumes that antibodies to the H-2" class II region, derived from both A.TL and C3H, are distinguishable in the backcross from H-2 k class I (C3H only).…”
Section: (Iv) Geneticsmentioning
confidence: 99%